Overall verdict
Neutral
5.1/10
1-year performance
+8.87%
Score breakdown
Up 8.9% over 1 year, 93% of the 52-week range.
Strongest: Shareholder return 8.1/10. Weakest: Growth 4.1/10.
15 analysts, target -0.1% vs the price.
Essity AB (publ) develops, produces, and sells hygiene and health products and services in Europe, North and Latin America, Asia, and internationally. The company operates through three segments: Health & Medical, Consumer Goods, and Professional Hygiene. The Health & Medical segment offers incontinence products, wound care, compression therapy, orthopedics, skincare products, and digital solutions with sensor technology under the TENA, Leukoplast, JOBST, Actimove, Cutimed, Delta-Cast, AquaCast Liner, and Hydrofera brands to family carers, professional caregivers, and patients and consumers through pharmacies, medical device stores, hospitals, distributors, care institutions, and e-commerce.
The Consumer Goods segment provides pads, panty liners, tampons, diapers, wet wipes, shampoos, lotions, baby oil, skin creams, intimate soaps, intimate wipes, leakproof apparel, menstrual cups, toilet papers, household towels, handkerchiefs, facial tissues, and napkins under the TENA, Knix, Modibodi, Libero, Lotus, Libresse, Bodyform, Nana, Saba, Nosotras, TOM Organic, Tempo, Zewa, Cushelle, Plenty, Regio, and Familia brands through retail trade and e-commerce.
The Professional Hygiene segment offers toilet papers, paper hand towels, napkins, hand soaps, hand lotions, hand sanitizers, dispensers, and cleaning and wiping products, as well as vision cleaning and data-driven cleaning solutions under the Tork brand to companies and office buildings, universities, healthcare facilities, airports, industries, restaurants, hotels, stadiums, and other public venues through direct to the end-customer, e-commerce, or distributors. Essity AB (publ) was founded in 1849 and is headquartered in Stockholm, Sweden.
Sector
Consumer Staples
Industry
Household Products
Primary listing
Omxsto
Sweden
CEO
Ulrika Kolsrud
Founded
1849
Employees
36 375
Revenue / employee
3.8M SEK
Next earnings
January 21, 2027
Research uses the underlying stock’s market history. The purchase quote is calculated separately when you review your order.
52-week high
293.80 SEK
52-week low
239.40 SEK
1-year performance
8.87%
Rising
Year-to-date performance
8.99%
Rising
Drawdown
-1.36%
Near its high
Position in the 52-week range
93% of range
Range: 316.55 SEK - 320.00 SEK (3 methods agree)
The price implies growth of 3.36% per year; the company grows at 4.75%.
Gross margin 31.7%, net margin 8.0%, ROIC 9.3%, ROE 12.3%.
Net margin
8.00%
Fair
Sector 8.65%|S&P 13.40%
Gross margin
31.69%
Fair
Return on equity (ROE)
12.31%
Fair
Sector 12.90%|S&P 17.06%
Return on invested capital (ROIC)
9.34%
Fair
Free cash flow margin (FCF)
8.58%
Fair
Profit-to-cash conversion (FCF conversion)
1.07x
High
Margin stability
1.8 pts
Very steady
Revenue to net income
Growth
4.1/10Revenue up 4.1% over 1 year, 2.6% a year over 5, EPS 4.8% a year over 5.
Revenue (trailing 12 months)
128Md SEK
Revenue growth (1y)
4.11%
Strong
Revenue growth (3y)
5.46%
Moderate
EPS growth (1y)
6.40%
Hyper-growth
EPS CAGR (5y)
4.75%
Exceptional
EPS revisions (3 months)
-1.18%
Revised down
Valuation
4.7/10P/E 17.7x, forward P/E 17.7x, EV/EBITDA 10.5x, PEG 3.73. The multiple sits in the 28th percentile of its own 5-year history.
P/E (TTM)
17.7x
Fair
Sector 19.8x|S&P 23.6x
Forward P/E
17.7x
Fair
EV / EBITDA
10.5x
Fair
Sector 10.5x|S&P 15.5x
PEG
3.73
Very expensive
Sector 2.28|S&P 0.91
Fair value (reverse DCF)
318.27 SEK
Fairly priced
P/E vs its own 5-year history
among the 28% lowest valuations
Cheaper than usual
Market cap
193Md SEK
Financial strength
7.9/10Cash covers 16.7% of the debt, net debt/EBITDA 1.1x.
Net debt / EBITDA
1.1x
Solid
Gearing (net debt / equity)
33.47%
Solid
Cash
6.0Md SEK
Cash / market cap
3.12%
Tight
Cash / total debt
16.71%
Tight
Interest coverage
13.4x
Very solid
Net debt
30.1Md SEK
Equity
89.8Md SEK
Closed daily candles, 2 years
Last close on November 11, 2026: 286.50 SEK
- MM20280.58
- MM50270.14
- MM200266.88
- RSI 1463.0
Top panel: closed candles, 20, 50 and 200-day moving averages, with volume in grey. Bottom panel: 14-day RSI with dashed 30 and 70 levels.
200-day average slope, 1 month
+0.65%
200-day average slope, 3 months
+1.04%
50-day average slope, 1 month
+0.35%
Price structure
Lower lows
Bullish RSI divergence
No
20-day volatility
1.16 % per day
Volatility change
+2.11%
Forecasts by fiscal year
| Fiscal year | EPS | Normalised EPS | Revenue | EBITDA | Net income |
|---|---|---|---|---|---|
| 2026 | 16.35 (11) | 18.66 (15) | 140 993 (13) | 25 015 (8) | 11 020 (9) |
| 2027 | 19.02 (11) | 19.91 (15) | 147 756 (14) | 26 227 (9) | 12 694 (10) |
Amounts in millions of SEK, EPS in SEK per share. In brackets, the number of analysts. Consensus as of November 3, 2026.
Same sub-industry: 36 companies behind the medians.
| # | Company | Code | Country | Overall / 10 | Fundamentals / 10 | Mkt cap | P/E | Net margin | Revenue growth | ROIC | Net debt / EBITDA | FCF yield | 1-year perf. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | RKT | 6.5 | 6.6 | 47.5Md USD | 13.0x | 21.2 % | 0.3 % | 22.4 % | 1.7x | 4.3 % | -4.0 % | ||
| 2 | HEN3 | 6.1 | 6.1 | 36.8Md USD | 16.7x | 9.4 % | -5.1 % | 8.3 % | 0.2x | 6.3 % | 16.3 % | ||
| 3 | PG | 5.8 | 5.7 | 389Md USD | 25.3x | 18.2 % | 4.0 % | 20.7 % | 1.0x | 3.9 % | 14.9 % | ||
| 4 | KMB | 5.6 | 6.3 | 66.8Md USD | 11.0x | 10.5 % | -0.4 % | 21.0 % | 2.1x | 2.9 % | 5.3 % | ||
| 5 | 8113 | 5.6 | 4.9 | 12.5Md USD | 31.1x | 6.2 % | 5.3 % | 7.8 % | -1.9x | 5.0 % | 15.0 % | ||
| 6 | CHD | 5.4 | 5.2 | 26.4Md USD | 34.5x | 12.4 % | 1.0 % | 11.9 % | 1.5x | 4.0 % | 31.7 % | ||
| 7 | CLX | 5.3 | 5.1 | 12.9Md USD | 19.2x | 9.4 % | 33.3 % | 19.2 % | 4.8x | 3.5 % | 1.8 % | ||
| 8 | CL | 5.1 | 4.8 | 77.9Md USD | 38.3x | 9.6 % | 4.6 % | 26.3 % | 1.5x | 4.9 % | 24.4 % | ||
| 9 | ESSITY B | 5.1 | 5.5 | 19.4Md USD | 17.7x | 8.0 % | 4.1 % | 9.3 % | 1.1x | 5.7 % | 8.9 % |
